Suppr超能文献

复合口服治疗对人体多种放射性核素体内污染及¹³¹I甲状腺摄取的影响

The effect of composite oral treatment for internal contamination with several radionuclides on 131I thyroid uptake in humans.

作者信息

Simonović I, Kargacin B, Kostial K

出版信息

J Appl Toxicol. 1986 Apr;6(2):109-11. doi: 10.1002/jat.2550060208.

Abstract

The efficiency of a composite oral treatment on 131I thyroid uptake was investigated in three adult volunteers. The treatment consisted of 10 g of calcium alginate, 3 g ferrihexacyanoferrate(II), 130 mg of potassium iodide and 5 g of Zn-DTPA. This mixture when administered 30 min before 131I almost completely blocked the 131I thyroid uptake. This indicates that simultaneous administration of other antidotal agents do not cancel or decrease the effect of potassium iodide on 131I thyroid uptake. The finding deserves attention since composite oral treatment is the recommended therapy in cases of accidental environmental exposure to several radionuclides.

摘要

在三名成年志愿者中研究了一种复合口服疗法对¹³¹I甲状腺摄取的效果。该疗法由10克海藻酸钙、3克亚铁氰化铁(II)、130毫克碘化钾和5克锌二乙三胺五乙酸组成。在¹³¹I给药前30分钟给予这种混合物几乎完全阻断了¹³¹I甲状腺摄取。这表明同时给予其他解毒剂不会消除或降低碘化钾对¹³¹I甲状腺摄取的作用。由于复合口服疗法是意外环境暴露于多种放射性核素情况下的推荐疗法,这一发现值得关注。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验